JESSICA HENNINGSEN: Open Payments
NPI 1699225482 · PROSPECT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 22 payments from 10 companies in 2025. Trend: 2023 $629 · 2024 $1,211 · 2025 $690
Food & beverage: $600Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $321 |
| Incyte Corporation | 4 | $84 |
| ABBVIE INC. | 4 | $71 |
| Almirall LLC | 2 | $52 |
| Lilly USA, LLC | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: TREMFYA, OPZELURA, Klisyri, SKYRIZI, RINVOQ, ILUMYA, EBGLYSS, SPEVIGO.
Industry payments across KY — which companies pay providers there.
